5 Stocks Insiders are Buying Now

1. Dyne Therapeutics, Inc. (NASDAQ:DYN)

Number of Hedge Fund Holders: 17

Dyne Therapeutics, Inc. (NASDAQ:DYN) is a leading biotechnology company focused on developing breakthrough therapies for patients with serious genetic and degenerative muscle diseases. On November 29, JPMorgan analyst Tessa Romero updated her price target on Dyne Therapeutics, Inc. (NASDAQ:DYN) to $18 from $24 and maintained an Overweight rating on the shares.

On December 14, Dyne Therapeutics, Inc. (NASDAQ:DYN) reported that director Jason Rhodes acquired 934,581 shares of the company’s common stock at $10.70 per share. The transaction was valued at $10 million. Dyne Therapeutics, Inc. (NASDAQ:DYN) is a stock that insiders are piling into right now.

At the end of Q3 2022, 17 hedge funds were bullish on Dyne Therapeutics, Inc. (NASDAQ:DYN) and disclosed positions worth $163 million in the company. This is compared to 19 positions in the previous quarter worth $120.5 million. As of September 30, Deep Track Capital is the dominant investor in the company and has a position worth $40.4 million.

You can also take a look at 10 Stocks Most Affected By Inflation and 10 Biggest Dividend Cuts of 2022.